YOU ASKED FOR MORE ? EVEN KIDS ARE NOT IMMUNE !
JULY 2000
The law firm of Waters & Kauff has filed a class action lawsuit against Novartis in Texas as "Hernandez, Plaintiff, Individually and on Behalf of all others Similarly Situated v. Ciba Geigy Corporation, U.S.A., Novartis Pharmaceuticals Corporation,
The lawsuit claims that the Novartis Corporation improperly promoted the use of Ritalin in order to increase its sales. In addition, the lawsuit lists a
series of neurological and cardiovascular side effects that the plaintiffs claim Novartis does not accurately relay to its customers.
plaintiffs' lawyers filed two suits, alleging that the maker of Ritalin, the commonly prescribed attention-deficit treatment, conspired with a psychiatric group to "create" a disease, and later hyped the drug's benefits.
ADHD has been over-diagnosed, and that Ritalin has been over-prescribed, including among many preschool children. Critics also say the long-term side-effects of Ritalin haven't been adequately studied
May 27, 1999
Doan's Pills Must Run Corrective Advertising:
FTC Ads Claiming Doan's Is Superior In Treating Back Pain Were Unsubstantiated
The Federal Trade Commission has ordered the makers of Doan's Pills to run ads to correct misbeliefs resulting from their unsubstantiated claim that Doan's Pills are superior to other over-the-counter analgesics for treating back pain. The Order, contained in a Commission opinion announced today, would require advertising and packaging to carry the message, "Although Doan's is an effective pain reliever, there is no evidence that Doan's is more effective than other pain relievers for back pain." The order also would prohibit Novartis Corporation and Novartis Consumer Health, Inc., the marketers of Doan's, from representing that the product is more effective than other over-the-counter products unless they possess and rely upon competent and reliable scientific evidence -- including at least two clinical studies -- to substantiate their claims
